Literature DB >> 9088935

Plasma cytokines in graft vs host disease and complications following bone marrow transplantation.

A N Abdallah1, J M Boiron, Y Attia, A Cassaigne, J Reiffers, A Iron.   

Abstract

A cohort of 201 autologous or allogeneic bone marrow transplanted (BMT) patients were included for studying the evolution of circulating tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) by means of repeated plasma determinations. IL-6 levels were high during major transplant-related complications (TRC) or severe graft vs host disease (GVHD). High levels of TNF-alpha seemed to be associated with chronic GVHD but not with acute GVHD or TRC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088935     DOI: 10.1007/s00282-997-0027-2

Source DB:  PubMed          Journal:  Hematol Cell Ther        ISSN: 1269-3286


  6 in total

Review 1.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

Review 2.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

3.  Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation.

Authors:  S A Rayner; W J King; R M Comer; J D Isaacs; G Hale; A J George; D F Larkin
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 4.  Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Authors:  Sophie Paczesny; Christine Duncan; David Jacobsohn; Robert Krance; Kathryn Leung; Paul Carpenter; Catherine Bollard; Jamie Renbarger; Kenneth Cooke
Journal:  Proteomics Clin Appl       Date:  2014-10-30       Impact factor: 3.494

5.  Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide.

Authors:  Giuseppe Lia; Clara Di Vito; Stefania Bruno; Marta Tapparo; Lucia Brunello; Armando Santoro; Jacopo Mariotti; Stefania Bramanti; Elisa Zaghi; Michela Calvi; Lorenzo Comba; Martina Fascì; Luisa Giaccone; Giovanni Camussi; Eileen M Boyle; Luca Castagna; Andrea Evangelista; Domenico Mavilio; Benedetto Bruno
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

6.  Kinetics of T helper subsets and associated cytokines correlate well with the clinical activity of graft-versus-host disease.

Authors:  Su-Peng Yeh; Yu-Min Liao; Wen-Jyi Lo; Chiao-Lin Lin; Li-Yuan Bai; Chen-Yuan Lin; Ching-Yun Hsieh; Yu-Chien Chang; Yu-Ting Huang; Chang-Fang Chiu
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.